The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • e-health SaaS provider Jayex Healthcare (JHL) has appointed Nick Harper as a Non-Executive Director, effective immediately
  • Mr Harper has worked in software development for over 30 years, in local government, investment banking and the aviation sector
  • The company has also completed a $700,000 placement, funds from which will support the rollout of new products for the Jayex Connect Platform and enable the company to explore new acquisition opportunities
  • In early afternoon trade, shares were up 36.7 per cent at 4.1 cents

e-health SaaS provider Jayex Healthcare (JHL) has appointed Nick Harper as a Non-Executive Director, effective immediately.

Mr Harper is based in the United Kingdom and has worked in software development for over 30 years, in local government, investment banking and the aviation sector.

He has worked on implementing and maintaining various types of software systems including batch valuation systems and real-time data processing and more recently been focused on product management and ownership.

Jayex Executive Chairman Michael Boyd said he was delighted that Mr Harper had agreed to join the board.

“His experience, energy and knowledge will enhance the leadership of the company. I look forward to working with him going forward.”

Completes $700,000 placement

The company has also placed 25,000,000 shares to institutional and sophisticated investors at 2.8 cents, raising $700,000.

The funds from the placement will support the rollout of new products on the Jayex Connect Platform, used by GPs and hospital in Australia, New Zealand and the United Kingdom.

New offering to be brought to the platform includes a remote monitoring application for fever and flu-like symptoms, licenced from Lifespot Health.

The Executive Chairman said that after 40 years of operations, the company is transitioning to a cloud-based model.

“Our transition to a cloud-based model is allowing us to evolve the platform, deploy new products rapidly, and ultimately create the opportunity to grow revenue by deepening our relationship with our long-standing existing customer base, and continue to expand into new sites.”

Additionally, funds from the equity raise will enable the company to explore new acquisition opportunities as they arise.

Shares were up 36.7 per cent at 4.1 cents at 1:30 pm AEST.

JHL by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…